Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 7 |
NetGPI | no | yes: 0, no: 7 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 7 |
GO:0110165 | cellular anatomical entity | 1 | 7 |
GO:0005789 | endoplasmic reticulum membrane | 4 | 1 |
GO:0031090 | organelle membrane | 3 | 1 |
Related structures:
AlphaFold database: A4HPC0
Term | Name | Level | Count |
---|---|---|---|
GO:0006629 | lipid metabolic process | 3 | 8 |
GO:0008152 | metabolic process | 1 | 8 |
GO:0008610 | lipid biosynthetic process | 4 | 8 |
GO:0009058 | biosynthetic process | 2 | 8 |
GO:0044238 | primary metabolic process | 2 | 8 |
GO:0071704 | organic substance metabolic process | 2 | 8 |
GO:1901576 | organic substance biosynthetic process | 3 | 8 |
GO:0006694 | steroid biosynthetic process | 5 | 1 |
GO:0008202 | steroid metabolic process | 4 | 1 |
GO:0016125 | sterol metabolic process | 4 | 1 |
GO:0016126 | sterol biosynthetic process | 5 | 1 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 1 |
GO:1901362 | organic cyclic compound biosynthetic process | 4 | 1 |
GO:1901615 | organic hydroxy compound metabolic process | 3 | 1 |
GO:1901617 | organic hydroxy compound biosynthetic process | 4 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 8 |
GO:0005488 | binding | 1 | 8 |
GO:0005506 | iron ion binding | 6 | 8 |
GO:0016491 | oxidoreductase activity | 2 | 8 |
GO:0043167 | ion binding | 2 | 8 |
GO:0043169 | cation binding | 3 | 8 |
GO:0046872 | metal ion binding | 4 | 8 |
GO:0046914 | transition metal ion binding | 5 | 8 |
GO:0000254 | C-4 methylsterol oxidase activity | 5 | 1 |
GO:0004497 | monooxygenase activity | 3 | 1 |
GO:0016705 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen | 3 | 1 |
GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen | 4 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 115 | 117 | PF00675 | 0.402 |
CLV_NRD_NRD_1 | 123 | 125 | PF00675 | 0.297 |
CLV_PCSK_KEX2_1 | 115 | 117 | PF00082 | 0.360 |
CLV_PCSK_SKI1_1 | 189 | 193 | PF00082 | 0.586 |
CLV_PCSK_SKI1_1 | 197 | 201 | PF00082 | 0.490 |
CLV_PCSK_SKI1_1 | 6 | 10 | PF00082 | 0.464 |
DEG_MDM2_SWIB_1 | 315 | 323 | PF02201 | 0.308 |
DEG_Nend_UBRbox_2 | 1 | 3 | PF02207 | 0.641 |
DOC_CKS1_1 | 250 | 255 | PF01111 | 0.308 |
DOC_CKS1_1 | 63 | 68 | PF01111 | 0.285 |
DOC_CYCLIN_yCln2_LP_2 | 148 | 154 | PF00134 | 0.354 |
DOC_CYCLIN_yCln2_LP_2 | 63 | 69 | PF00134 | 0.350 |
DOC_MAPK_gen_1 | 189 | 198 | PF00069 | 0.364 |
DOC_PP2B_LxvP_1 | 109 | 112 | PF13499 | 0.546 |
DOC_PP2B_LxvP_1 | 148 | 151 | PF13499 | 0.363 |
DOC_USP7_MATH_1 | 280 | 284 | PF00917 | 0.302 |
DOC_USP7_UBL2_3 | 121 | 125 | PF12436 | 0.557 |
DOC_USP7_UBL2_3 | 5 | 9 | PF12436 | 0.667 |
DOC_WW_Pin1_4 | 175 | 180 | PF00397 | 0.444 |
DOC_WW_Pin1_4 | 249 | 254 | PF00397 | 0.302 |
DOC_WW_Pin1_4 | 62 | 67 | PF00397 | 0.352 |
LIG_14-3-3_CanoR_1 | 17 | 25 | PF00244 | 0.572 |
LIG_14-3-3_CanoR_1 | 371 | 379 | PF00244 | 0.426 |
LIG_BRCT_BRCA1_1 | 268 | 272 | PF00533 | 0.203 |
LIG_BRCT_BRCA1_1 | 346 | 350 | PF00533 | 0.302 |
LIG_BRCT_BRCA1_1 | 86 | 90 | PF00533 | 0.216 |
LIG_FHA_1 | 154 | 160 | PF00498 | 0.423 |
LIG_FHA_1 | 239 | 245 | PF00498 | 0.265 |
LIG_FHA_1 | 304 | 310 | PF00498 | 0.308 |
LIG_FHA_1 | 337 | 343 | PF00498 | 0.259 |
LIG_FHA_1 | 36 | 42 | PF00498 | 0.411 |
LIG_FHA_1 | 384 | 390 | PF00498 | 0.409 |
LIG_FHA_1 | 63 | 69 | PF00498 | 0.281 |
LIG_FHA_2 | 176 | 182 | PF00498 | 0.378 |
LIG_FHA_2 | 250 | 256 | PF00498 | 0.308 |
LIG_FHA_2 | 274 | 280 | PF00498 | 0.308 |
LIG_FHA_2 | 373 | 379 | PF00498 | 0.452 |
LIG_FHA_2 | 382 | 388 | PF00498 | 0.461 |
LIG_LIR_Apic_2 | 249 | 253 | PF02991 | 0.302 |
LIG_LIR_Gen_1 | 218 | 227 | PF02991 | 0.380 |
LIG_LIR_Gen_1 | 269 | 275 | PF02991 | 0.287 |
LIG_LIR_Gen_1 | 297 | 307 | PF02991 | 0.302 |
LIG_LIR_Nem_3 | 213 | 219 | PF02991 | 0.346 |
LIG_LIR_Nem_3 | 264 | 270 | PF02991 | 0.295 |
LIG_LIR_Nem_3 | 297 | 303 | PF02991 | 0.302 |
LIG_LIR_Nem_3 | 70 | 76 | PF02991 | 0.334 |
LIG_LIR_Nem_3 | 87 | 92 | PF02991 | 0.218 |
LIG_MLH1_MIPbox_1 | 86 | 90 | PF16413 | 0.216 |
LIG_OCRL_FandH_1 | 232 | 244 | PF00620 | 0.302 |
LIG_Pex14_2 | 268 | 272 | PF04695 | 0.302 |
LIG_Pex14_2 | 315 | 319 | PF04695 | 0.302 |
LIG_Pex14_2 | 69 | 73 | PF04695 | 0.354 |
LIG_Pex14_2 | 85 | 89 | PF04695 | 0.354 |
LIG_PTB_Apo_2 | 83 | 90 | PF02174 | 0.354 |
LIG_SH2_CRK | 120 | 124 | PF00017 | 0.549 |
LIG_SH2_CRK | 155 | 159 | PF00017 | 0.363 |
LIG_SH2_CRK | 250 | 254 | PF00017 | 0.259 |
LIG_SH2_CRK | 50 | 54 | PF00017 | 0.400 |
LIG_SH2_GRB2like | 160 | 163 | PF00017 | 0.296 |
LIG_SH2_SRC | 361 | 364 | PF00017 | 0.277 |
LIG_SH2_STAP1 | 155 | 159 | PF00017 | 0.363 |
LIG_SH2_STAT5 | 147 | 150 | PF00017 | 0.346 |
LIG_SH2_STAT5 | 155 | 158 | PF00017 | 0.202 |
LIG_SH2_STAT5 | 160 | 163 | PF00017 | 0.331 |
LIG_SH2_STAT5 | 217 | 220 | PF00017 | 0.259 |
LIG_SH2_STAT5 | 240 | 243 | PF00017 | 0.259 |
LIG_SH2_STAT5 | 267 | 270 | PF00017 | 0.307 |
LIG_SH2_STAT5 | 275 | 278 | PF00017 | 0.311 |
LIG_SH2_STAT5 | 30 | 33 | PF00017 | 0.354 |
LIG_SH2_STAT5 | 313 | 316 | PF00017 | 0.271 |
LIG_SH2_STAT5 | 361 | 364 | PF00017 | 0.333 |
LIG_SH2_STAT5 | 59 | 62 | PF00017 | 0.416 |
LIG_SH3_3 | 42 | 48 | PF00018 | 0.306 |
LIG_SH3_3 | 5 | 11 | PF00018 | 0.632 |
LIG_SUMO_SIM_par_1 | 150 | 156 | PF11976 | 0.247 |
LIG_SUMO_SIM_par_1 | 197 | 203 | PF11976 | 0.343 |
LIG_TRAF2_1 | 276 | 279 | PF00917 | 0.308 |
LIG_TYR_ITIM | 153 | 158 | PF00017 | 0.427 |
LIG_WRC_WIRS_1 | 216 | 221 | PF05994 | 0.203 |
LIG_WRC_WIRS_1 | 267 | 272 | PF05994 | 0.243 |
MOD_CK2_1 | 249 | 255 | PF00069 | 0.302 |
MOD_CK2_1 | 273 | 279 | PF00069 | 0.385 |
MOD_Cter_Amidation | 113 | 116 | PF01082 | 0.352 |
MOD_GlcNHglycan | 130 | 133 | PF01048 | 0.450 |
MOD_GlcNHglycan | 186 | 189 | PF01048 | 0.611 |
MOD_GlcNHglycan | 282 | 285 | PF01048 | 0.508 |
MOD_GlcNHglycan | 287 | 290 | PF01048 | 0.537 |
MOD_GlcNHglycan | 310 | 313 | PF01048 | 0.459 |
MOD_GlcNHglycan | 346 | 349 | PF01048 | 0.502 |
MOD_GSK3_1 | 135 | 142 | PF00069 | 0.427 |
MOD_GSK3_1 | 218 | 225 | PF00069 | 0.318 |
MOD_GSK3_1 | 238 | 245 | PF00069 | 0.335 |
MOD_GSK3_1 | 280 | 287 | PF00069 | 0.324 |
MOD_N-GLC_2 | 162 | 164 | PF02516 | 0.596 |
MOD_N-GLC_2 | 341 | 343 | PF02516 | 0.508 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.663 |
MOD_NEK2_1 | 139 | 144 | PF00069 | 0.326 |
MOD_NEK2_1 | 158 | 163 | PF00069 | 0.543 |
MOD_NEK2_1 | 285 | 290 | PF00069 | 0.354 |
MOD_NEK2_1 | 294 | 299 | PF00069 | 0.265 |
MOD_NEK2_1 | 315 | 320 | PF00069 | 0.265 |
MOD_NEK2_1 | 336 | 341 | PF00069 | 0.302 |
MOD_NEK2_1 | 55 | 60 | PF00069 | 0.376 |
MOD_NEK2_1 | 84 | 89 | PF00069 | 0.331 |
MOD_NEK2_1 | 91 | 96 | PF00069 | 0.592 |
MOD_NEK2_2 | 12 | 17 | PF00069 | 0.488 |
MOD_NEK2_2 | 215 | 220 | PF00069 | 0.222 |
MOD_OFUCOSY | 157 | 164 | PF10250 | 0.336 |
MOD_PIKK_1 | 372 | 378 | PF00454 | 0.389 |
MOD_PKA_2 | 370 | 376 | PF00069 | 0.455 |
MOD_Plk_4 | 135 | 141 | PF00069 | 0.357 |
MOD_Plk_4 | 218 | 224 | PF00069 | 0.303 |
MOD_Plk_4 | 294 | 300 | PF00069 | 0.319 |
MOD_Plk_4 | 315 | 321 | PF00069 | 0.302 |
MOD_Plk_4 | 55 | 61 | PF00069 | 0.467 |
MOD_Plk_4 | 84 | 90 | PF00069 | 0.211 |
MOD_ProDKin_1 | 175 | 181 | PF00069 | 0.440 |
MOD_ProDKin_1 | 249 | 255 | PF00069 | 0.302 |
MOD_ProDKin_1 | 62 | 68 | PF00069 | 0.346 |
TRG_ENDOCYTIC_2 | 147 | 150 | PF00928 | 0.354 |
TRG_ENDOCYTIC_2 | 155 | 158 | PF00928 | 0.234 |
TRG_ENDOCYTIC_2 | 230 | 233 | PF00928 | 0.259 |
TRG_ENDOCYTIC_2 | 267 | 270 | PF00928 | 0.293 |
TRG_ENDOCYTIC_2 | 50 | 53 | PF00928 | 0.320 |
TRG_ER_diArg_1 | 115 | 117 | PF00400 | 0.564 |
TRG_ER_diArg_1 | 330 | 333 | PF00400 | 0.302 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PEE3 | Leptomonas seymouri | 60% | 98% |
A0A0S4JXU3 | Bodo saltans | 36% | 100% |
A0A3Q8IKR9 | Leishmania donovani | 79% | 98% |
A4ICG0 | Leishmania infantum | 79% | 98% |
E9AT31 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 75% | 98% |
Q4Q1G7 | Leishmania major | 76% | 100% |